Cytek Biosciences
CTKB
CTKB
154 hedge funds and large institutions have $414M invested in Cytek Biosciences in 2025 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 52 increasing their positions, 60 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
1.25% more ownership
Funds ownership: 62.9% → 64.15% (+1.2%)
1% more funds holding
Funds holding: 153 → 154 (+1)
13% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 60
Holders
154
Holding in Top 10
2
Calls
$38K
Puts
$28K
Top Buyers
| 1 | +$23.1M | |
| 2 | +$6.19M | |
| 3 | +$3.91M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$3.19M |
| 5 |
BlackRock
New York
|
+$2.9M |
Top Sellers
| 1 | -$13.4M | |
| 2 | -$8.25M | |
| 3 | -$2.65M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$2.6M |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
-$1.38M |
